Royal London Asset Management LTD Johnson & Johnson Transaction History

Royal London Asset Management LTD

$39.3 Billion
Q1 2024

A detailed history of Royal London Asset Management LTD transactions in Johnson & Johnson stock. As of the latest transaction made, Royal London Asset Management LTD holds 1,696,539 shares of JNJ stock, worth $248 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares

1,696,539

Previous 1,619,599 4.75%

Holding current value

$248 Million

Previous $254 Million 5.72%

% of portfolio

0.68%

Previous 0.74%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$155.22 - $162.74 $11.9 Million - $12.5 Million	76,940 Added 4.75%	1,696,539 $268 Million
Q4 2023 Feb 13, 2024	BUY	$145.6 - $158.88 $7.73 Million - $8.44 Million	53,116 Added 3.39%	1,619,599 $254 Million
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $18.3 Million - $20.5 Million	-117,348 Reduced 6.97%	1,566,483 $244 Million
Q2 2023 Aug 11, 2023	BUY	$154.35 - $166.11 $45.9 Million - $49.4 Million	297,638 Added 21.47%	1,683,831 $279 Million
Q1 2023 May 15, 2023	BUY	$151.05 - $180.26 $25.6 Million - $30.6 Million	169,687 Added 13.95%	1,386,193 $215 Million

Q4 2022 Feb 09, 2023	BUY	$160.2 - $179.79 $4.31 Million - $4.83 Million	26,875 Added 2.26%	1,216,506 $215 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $9.78 Million - $10.9 Million	-60,645 Reduced 4.85%	1,189,631 $195 Million
Q2 2022 Aug 12, 2022	SELL	$168.19 - $186.01 $1.16 Million - $1.28 Million	-6,905 Reduced 0.55%	1,250,276 $222 Million
Q1 2022 May 13, 2022	BUY	$158.14 - $179.59 $7.44 Million - $8.45 Million	47,031 Added 3.89%	1,257,181 $223 Million
Q4 2021 Oct 18, 2022	SELL	$155.93 - $173.01 $9.39 Million - $10.4 Million	-60,228 Reduced 4.74%	1,210,150 $207 Million
Q4 2021 Jan 18, 2022	SELL	$155.93 - $173.01 $9.39 Million - $10.4 Million	-60,228 Reduced 4.74%	1,210,150 $207 Million
Q3 2021 Oct 18, 2022	SELL	$161.5 - $179.47 $12.4 Million - $13.8 Million	-76,807 Reduced 5.7%	1,270,378 $205 Million
Q3 2021 Nov 02, 2021	SELL	$161.5 - $179.47 $12.4 Million - $13.8 Million	-76,807 Reduced 5.7%	1,270,378 $205 Million
Q2 2021 Oct 18, 2022	BUY	$159.48 - $171.07 $15.5 Million - $16.6 Million	96,909 Added 7.75%	1,347,185 $222 Million
Q2 2021 Jul 14, 2021	SELL	$159.48 - $171.07 $14.8 Million - $15.8 Million	-92,544 Reduced 6.43%	1,347,185 $224 Million
Q1 2021 Oct 17, 2022	BUY	$153.07 - $170.48 $29 Million - $32.3 Million	189,453 Added 15.15%	1,439,729 $237 Million
Q1 2021 Apr 13, 2021	SELL	$153.07 - $170.48 $26 Million - $28.9 Million	-169,688 Reduced 10.54%	1,439,729 $237 Million
Q4 2020 Jan 29, 2021	SELL	$137.11 - $157.38 $167,411 - $192,160	-1,221 Reduced 0.08%	1,609,417 $253 Million
Q3 2020 Nov 04, 2020	BUY	$140.38 - $153.83 $21.7 Million - $23.7 Million	154,259 Added 10.59%	1,610,638 $237 Million
Q2 2020 Jul 31, 2020	SELL	$128.81 - $155.51 $7.62 Million - $9.2 Million	-59,138 Reduced 3.9%	1,456,379 $203 Million
Q1 2020 May 01, 2020	BUY	$111.14 - $153.99 $1.9 Million - $2.64 Million	17,114 Added 1.14%	1,515,517 $201 Million
Q4 2019 Feb 05, 2020	BUY	$127.5 - $146.44 $4.36 Million - $5.01 Million	34,215 Added 2.34%	1,498,403 $218 Million
Q3 2019 Nov 12, 2019	SELL	$126.95 - $142.14 $83,279 - $93,243	-656 Reduced 0.04%	1,464,188 $189 Million
Q2 2019 Jul 31, 2019	BUY	$131.15 - $144.24 $2.66 Million - $2.93 Million	20,313 Added 1.41%	1,464,844 $204 Million
Q1 2019 Apr 30, 2019	SELL	$125.72 - $139.79 $53.4 Million - $59.4 Million	-424,782 Reduced 22.72%	1,444,531 $0
Q4 2018 Jan 29, 2019	BUY	$122.84 - $147.84 $79.7 Million - $95.9 Million	648,775 Added 53.15%	1,869,313 $199 Million
Q3 2018 Nov 08, 2018	SELL	$121.58 - $142.88 $2.46 Million - $2.89 Million	-20,248 Reduced 1.63%	1,220,538 $0
Q2 2018 Sep 19, 2018	BUY	$119.4 - $131.76 $148 Million - $163 Million	1,240,786 New	1,240,786 $151 Million

Others Institutions Holding JNJ

# of Institutions

4,146

Shares Held

1.64B

Call Options Held

15.1M

Put Options Held

12.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $382B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Royal London Asset Management LTD with notifications on news.

Account

Royal London Asset Management LTD Johnson & Johnson Transaction History